Both in Pharmaceuticals
PTC Therapeutics vs Oruka Therapeutics
Over the past year PTCT returned +7.1% and ORKA returned +325.9%; their daily moves had a correlation of 0.35.
PTCT +7.1% ORKA +325.9%Growth of $1, one year, split-adjusted
| Metric | PTCT | ORKA |
|---|---|---|
| Price | $64.96 | $82.15 |
| Market cap | $5.42B | $5.44B |
| Today | −1.50% | −2.42% |
| 1 month | −7.3% | −9.9% |
| 6 months | −1.0% | +80.5% |
| Year to date | −14.5% | +171.0% |
| 1 year | +10.1% | +440.5% |
| Revenue growth (YoY) | +101.5% | — |
| Gross margin | 94.5% | — |
| Net margin | 23.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.4× | — |
| Net cash | $1.63B | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 52.3% |
| Short % of float | 12.4% | 15.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).